-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Biopharma Announces $5M Common Stock Buyback Plan

Benzinga·06/11/2026 12:34:06
Listen to the news

Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced it has approved a share repurchase program authorizing the Company to repurchase up to $5.0 million of its common stock.